TrianglePUBLICATIONS · 10561225
Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1999 Jun
- First author
- Davis TA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Davis TA
- type
- Author
- name
- White CA
- type
- Author
- name
- Grillo-López AJ
- type
- Author
- name
- Velásquez WS
- type
- Author
- name
- Link B
- type
- Author
- name
- Maloney DG
- type
- Author
- name
- Dillman RO
- type
- Author
- name
- Williams ME
- type
- Author
- name
- Mohrbacher A
- type
- Author
- name
- Weaver R
- type
- Author
- name
- Dowden S
- type
- Author
- name
- Levy R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Davis TA
- type
- Author
- name
- White CA
- type
- Author
- name
- Grillo-López AJ
- type
- Author
- name
- Velásquez WS
- type
- Author
- name
- Link B
- type
- Author
- name
- Maloney DG
- type
- Author
- name
- Dillman RO
- type
- Author
- name
- Williams ME
- type
- Author
- name
- Mohrbacher A
- type
- Author
- name
- Weaver R
- type
- Author
- name
- Dowden S
- type
- Author
- name
- Levy R
- type
- Author
- bibliography ids
- nci-bib-1a5baf81c1843d893d76c1e9
- book metadata
- content sha256
- f7c031e2a22fe21c08906dce7e5a243f0812b31e950ebe8f2eef5d2dc58aec2e
- document type
- citation
- dois
- 10.1200/JCO.1999.17.6.1851
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:10561225
- immutable id
- pubmed:10561225@f7c031e2a22fe21c08906dce7e5a243f0812b31e950ebe8f2eef5d2dc58aec2e
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 6
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1851-7
- volume
- 17
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 10561225
- provenance
- batch id
- 40703d4bdd5a70d2c67a
- provider
- NCBI PubMed ESummary
- record sha256
- c39e28d3e4a891dd63c2e8310f477edc1f4729f68295ee30a2e8bb666c184fcb
- response sha256
- a3c61c2ff7d134e39b75494c75710402933a0e6adc127aa6cbdffc11682a963b
- retrieved at
- 2026-09-09T23:45:35.800055+00:00
- publication date
- display
- 1999 Jun
- precision
- month
- year
- 1999
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: results of a phase II trial of rituximab.
Preserved source evidence · Independent clinical review pending · Not medical advice